West Michigan Advisors LLC Purchases 561 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

West Michigan Advisors LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 23.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,931 shares of the healthcare conglomerate’s stock after purchasing an additional 561 shares during the period. West Michigan Advisors LLC’s holdings in UnitedHealth Group were worth $1,714,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Wealthcare Advisory Partners LLC lifted its position in UnitedHealth Group by 6.3% during the first quarter. Wealthcare Advisory Partners LLC now owns 5,512 shares of the healthcare conglomerate’s stock valued at $2,727,000 after purchasing an additional 326 shares during the last quarter. Signet Financial Management LLC lifted its stake in UnitedHealth Group by 8.0% during the first quarter. Signet Financial Management LLC now owns 725 shares of the healthcare conglomerate’s stock worth $358,000 after purchasing an additional 54 shares during the last quarter. 180 Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 40.9% during the 1st quarter. 180 Wealth Advisors LLC now owns 1,939 shares of the healthcare conglomerate’s stock valued at $959,000 after purchasing an additional 563 shares during the last quarter. Capital Asset Advisory Services LLC lifted its position in UnitedHealth Group by 9.8% in the 1st quarter. Capital Asset Advisory Services LLC now owns 7,125 shares of the healthcare conglomerate’s stock worth $3,247,000 after buying an additional 638 shares during the last quarter. Finally, AMF Tjanstepension AB raised its stake in shares of UnitedHealth Group by 113.3% during the first quarter. AMF Tjanstepension AB now owns 197,274 shares of the healthcare conglomerate’s stock worth $97,618,000 after acquiring an additional 104,798 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on UNH shares. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Truist Financial reissued a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Finally, Barclays cut their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Down 0.7 %

NYSE UNH opened at $560.82 on Friday. The stock has a market cap of $517.87 billion, a P/E ratio of 36.54, a P/E/G ratio of 1.67 and a beta of 0.58. The stock’s fifty day moving average price is $584.16 and its 200-day moving average price is $536.49. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.